Island Pharmaceuticals Limited announced that Cameron Jones and Stephanie Vipond of Bio101 Financial Advisory ("Bio101) have been appointed as Joint Company Secretaries of the Company. The appointment will complement Cameron's role of Chief Financial Officer of the Company, which he has held since IPO. Cameron is the Managing Director of Bio101, a financial services firm providing accounting, tax and company secretarial services specialising in healthcare and life science sectors.

Stephanie is an experienced Company Secretary from Bio101, providing company secretarial services to a number of ASX listed and unlisted entities in the healthcare sector. Stephanie holds a Bachelor of Commerce and Law and a Certificate in Governance Practice. The appointment follows the resignation of Mr. Peter Webse as Company Secretary, effective 1 December 2023.